Minor Lloyd
Director
Sale 10b5-1
- Shares
- 593
- Price
- $200.96
- Value
- $119,169
SEC EDGAR · Forms 3/4/5Updated through Oct 30, 2026•40 filings
BIIB
BIOGEN INC.
Net sales of $239.7K over the last 3 months
1 seller account for the net balance. There is no cluster of three distinct buyers within 30 days. We found no CEO/CFO purchases over 12 months.
How to read this signal
Only open-market P purchases and S sales count toward the signal. Vesting, options, taxes and gifts remain in the source data but do not trigger alerts. Rule 10b5-1 trades are shown as informational.
3-month balance
−$239,750
0 buyers · 1 sellers
12-month purchases
$585.11
1 distinct insiders
12-month sales
$905,414
2 distinct insiders
Highlighted alerts
1
5 Rule 10b5-1 trades treated as informational
Buying cluster · 30 days
Fewer than three distinct buyers
CEO/CFO purchases · 12 months
No executive purchases found
Get BIIB insider trades by API
The same filtered trades as JSON for your scripts, alerts or AI agent, for 5,500+ US companies — plus sentiment, news, financials and breakout setups. Free · every API · 1,000 requests a month · no card required.
BIIB overview: breakout setup, X sentiment and insiders in one page →
Form 4 raw → Raspberry
The value is in what we do not call a signal.
The SEC XML stores every transaction. Raspberry keeps that evidence, reads the footnotes and separates voluntary open-market activity from vesting, option exercises, gifts, tax withholding, stock purchase and dividend reinvestment plans and pre-programmed 10b5-1 trades.
100
Raw transactions
Everything returned by the filing
6
Voluntary view
P/S trades after deterministic checks
96
Administrative noise
Stored, never alerted
9
10b5-1
Shown as informational
SEC ownership XML facts
- Code
- F
- Shares
- 8
- Price
- $219.88
- Footnotes
- 3
Includes 98.3178 shares acquired under the Biogen Inc. employee stock purchase plan on 3/31/2026, 6/30/2026, and 9/30/2026. The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of October 1, 2026. The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of October 2, 2023.
Recent transactions
Voluntary purchases and sales; administrative noise stays hidden.
Minor Lloyd
Director
Sale 10b5-1
- Shares
- 593
- Price
- $203.34
- Value
- $120,581
Murphy Nicole
Head of Pharm Ops and Tech
PurchaseAlert
- Shares
- 3
- Price
- $195.04
- Value
- $585.11
Singhal Priya
Head of Development
Sale 10b5-1
- Shares
- 2,660
- Price
- $199.83
- Value
- $531,548
Singhal Priya
Head of Development
Sale 10b5-1
- Shares
- 748
- Price
- $179.30
- Value
- $134,116
Singhal Priya
Head of Development
Sale 10b5-1
- Shares
- 517
- Price
- $133.55
- Value
- $69,045
| Date | Insider | Transaction | Shares | Price | Value | Reading |
|---|---|---|---|---|---|---|
| Aug 04, 2026 | Minor Lloyd Director | Sale | 593 | $200.96 | $119,169 | |
| Aug 03, 2026 | Minor Lloyd Director | Sale | 593 | $203.34 | $120,581 | |
| Feb 12, 2026 | Murphy Nicole Head of Pharm Ops and Tech | Purchase | 3 | $195.04 | $585.11 | |
| Feb 09, 2026 | Singhal Priya Head of Development | Sale | 2,660 | $199.83 | $531,548 | |
| Feb 02, 2026 | Singhal Priya Head of Development | Sale | 748 | $179.30 | $134,116 | |
| Sep 02, 2025 | Singhal Priya Head of Development | Sale | 517 | $133.55 | $69,045 |
“Alert” means a voluntary, unscheduled transaction according to the filing; it is not an investment recommendation. Official source: SEC EDGAR.